Serum adiponectin levels in patients with non-alcoholic fatty liver disease are an independent predictor of advanced fibrosis and are negatively correlated with the stage of liver fibrosis (Savvidou et al., 2009). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.